Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermia.
Riess
F C
FC
Department of Cardiac Surgery, Albertinen-Hospital, Hamburg, Germany. herzchirurgie@albertinen.de
Fiege
M
M
Moshar
S
S
Bergmann
H
H
Bleese
N
N
Kormann
J
J
Weisshorn
R
R
Wappler
F
F
D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D000242:Cyclic AMP / Q000502:physiology; D017335:Enoximone / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000150:complications*; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000209:etiology*
D010726:Phosphodiesterase Inhibitors; D017335:Enoximone; D000242:Cyclic AMP